logo
welcome
ScienceDaily

ScienceDaily

Study identifies potential new drug for Parkinson's-related cognitive decline, dementia

ScienceDaily
Summary
Nutrition label

78% Informative

A study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 appears to have a protective effect on brain cells.

Parkinson's disease, a neurological disorder, also causes cognitive symptoms that can progress to Parkinson's dementia.

There are medications that control the disease's motor symptoms, but there are no effective treatments for its cognitive symptoms.

The angiotensin ( 17 ) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation.

"PNA5 seems to have a possibility of stopping or delaying Parkinson's progression to some extent," Lalitha Madhavan said.

VR Score

89

Informative language

95

Neutral language

45

Article tone

formal

Language

English

Language complexity

61

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links